FLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Flowserve is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 ready to deploy immediately. The fundamentals are improving, analysts remain mostly positive, and hedge funds are buying, but the stock is still digesting a soft Q1, guidance risk, and a weak short-term technical setup. Since there is no AI Stock Picker or SwingMax buy signal today, I would not call this an immediate buy. Best direct view: hold and wait for a clearer entry above the current pre-market level or after the market confirms the post-earnings rebound.
FLS is in a short-term weak-to-neutral trend. MACD histogram is negative at -1.412 and still below zero, though contracting, which suggests downside momentum is easing rather than fully reversing. RSI_6 at 33.157 is near oversold but not yet a strong reversal signal. Moving averages are converging, which often signals a possible base-building phase. Price is trading around 71.77 pre-market, very close to support at 71.174, while the prior pivot is 78.36 and resistance sits at 85.545. The pattern-based trend data is also bearish over the near term, implying further downside pressure is still possible.
["Hedge funds are buying, with ownership increasing 262.44% over the last quarter.", "Multiple analysts kept Buy/Outperform ratings despite trimming price targets.", "Flowserve reaffirmed 2026 adjusted EPS guidance of $4.00 to $4.20.", "2026/Q1 net income, EPS, and gross margin all improved year over year.", "Longer-term catalysts include nuclear/AI electricity buildout and multi-year opportunity in the Middle East after disruption resolves."]
["2026/Q1 revenue fell 6.66% year over year, showing top-line pressure.", "Analysts broadly lowered price targets after Q1 results, signaling reduced near-term confidence.", "Goldman remained Neutral and warned organic growth guidance could require steep acceleration later in the year.", "The company issued $500 million of 5.7% senior notes, adding financing complexity tied to the Trillium acquisition.", "Short-term trend signals are weak, and similar candlestick patterns point to further downside over the next day, week, and month."]
In 2026/Q1, Flowserve showed mixed but improving profitability. Revenue declined to $1.068 billion, down 6.66% year over year, which is the main weakness. However, net income rose 10.52% to $81.68 million, EPS increased 14.29% to $0.64, and gross margin improved to 37.1%. That means profitability and efficiency are improving even while sales remain soft. For a long-term investor, the earnings quality trend is better than the revenue trend.
Analyst sentiment is still constructive but has turned more cautious on price targets after Q1. TD Cowen, Baird, Stifel, Citi, and Jefferies all kept Buy/Outperform-type views, while Goldman is Neutral. Several targets were cut: TD Cowen to $85 from $100, Baird to $91 from $97, Stifel to $92 from $102, Citi to $92 from $97, and Goldman to $83 from $86. Wall Street’s pro view is that Flowserve has margin expansion potential, AI/nuclear-related demand tailwinds, and a multi-year recovery setup. The con view is that near-term organic growth looks uncertain, Middle East disruption hurt results, and there may be more estimate cuts before the stock re-rates.
